1. Share Talk
  2. Pharmaceutical

Pharmaceutical

23May 2017

SkinBioTherapeutics PLC (AIM:SBTX) Extension of research contract with University of Manchester

SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, announces that, as envisaged in the Company’s Admission Document dated 29 March 2017, it has agreed an eight month extension to its research contract with the University of Manchester to June 2018. This contract extension includes provision for the appointment of a second technician to the Company. This will increase the Company’s ability to develop its SkinBiotix® platform.

3May 2017

N4 Pharma Plc (AIM:N4P) Admission to AIM/Interview with CEO

N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, is pleased to announce the readmission today of the Company’s ordinary shares to trading on AIM and the commencement of dealings in the New Ordinary Shares under the ticker N4P (“Admission”).

Share Talk took the opportunity to speak with N4 Pharma’s Founder and CEO Nigel Theobald following their admission and first day of shares being available for dealing on AIM .

2May 2017

Verditek Plc – Intention to float on AIM

Verditek plc, a holding company with three businesses operating within the clean technology sector with proven products considered as being at the point of commercialisation, is pleased to announce its intention to seek admission of its shares to trading on the AIM market of the London Stock Exchange (“Admission”). Dealings are expected to commence on AIM in May 2017.

29Apr 2017

Share Talk – Steve Shares 29th April

Welcome to Steve Shares. This publication is an interactive weekly update on what’s happening over social media and the trending stocks that have made the news this week. I highlight and comment on the coming news and events in connection with the trending stocks. I provide a round up of Share Talk’s key company interviews over the last week. If you think that a certain share or a key news item should be reported on be in the next edition, let me know by contacting me. My details are at the bottom of the page…

Page 1 of 212
DON’T MISS OUT!
Subscribe To Our Newsletter
Be the first to get latest updates and exclusive content straight to your email inbox.
Stay Updated
Give it a try, you can unsubscribe anytime.
Get the week’s best articles right in your inbox
Subscribe
Join 15K subscribers